table of content
1 Introduction to Research & Analysis Reports
1.1 Cancer Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Gene Therapy Overall Market Size
2.1 Global Cancer Gene Therapy Market Size: 2022 VS 2032
2.2 Global Cancer Gene Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Gene Therapy Players in Global Market
3.2 Top Global Cancer Gene Therapy Companies Ranked by Revenue
3.3 Global Cancer Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Gene Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Gene Therapy Players in Global Market
3.6.1 List of Global Tier 1 Cancer Gene Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Gene Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Gene Therapy Market Size Markets, 2022 & 2032
4.1.2 Oncolytic Virotherapy
4.1.3 Gene Transfer
4.1.4 Gene-Induced Immunotherapy
4.2 By Type - Global Cancer Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Cancer Gene Therapy Revenue, 2018-2023
4.2.2 By Type - Global Cancer Gene Therapy Revenue, 2024-2032
4.2.3 By Type - Global Cancer Gene Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Gene Therapy Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Diagnostics Centers
5.1.4 Research Institutes
5.2 By Application - Global Cancer Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Cancer Gene Therapy Revenue, 2018-2023
5.2.2 By Application - Global Cancer Gene Therapy Revenue, 2024-2032
5.2.3 By Application - Global Cancer Gene Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Cancer Gene Therapy Market Size, 2022 & 2032
6.2 By Region - Global Cancer Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Cancer Gene Therapy Revenue, 2018-2023
6.2.2 By Region - Global Cancer Gene Therapy Revenue, 2024-2032
6.2.3 By Region - Global Cancer Gene Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Cancer Gene Therapy Revenue, 2018-2032
6.3.2 US Cancer Gene Therapy Market Size, 2018-2032
6.3.3 Canada Cancer Gene Therapy Market Size, 2018-2032
6.3.4 Mexico Cancer Gene Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Cancer Gene Therapy Revenue, 2018-2032
6.4.2 Germany Cancer Gene Therapy Market Size, 2018-2032
6.4.3 France Cancer Gene Therapy Market Size, 2018-2032
6.4.4 U.K. Cancer Gene Therapy Market Size, 2018-2032
6.4.5 Italy Cancer Gene Therapy Market Size, 2018-2032
6.4.6 Russia Cancer Gene Therapy Market Size, 2018-2032
6.4.7 Nordic Countries Cancer Gene Therapy Market Size, 2018-2032
6.4.8 Benelux Cancer Gene Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Cancer Gene Therapy Revenue, 2018-2032
6.5.2 China Cancer Gene Therapy Market Size, 2018-2032
6.5.3 Japan Cancer Gene Therapy Market Size, 2018-2032
6.5.4 South Korea Cancer Gene Therapy Market Size, 2018-2032
6.5.5 Southeast Asia Cancer Gene Therapy Market Size, 2018-2032
6.5.6 India Cancer Gene Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Cancer Gene Therapy Revenue, 2018-2032
6.6.2 Brazil Cancer Gene Therapy Market Size, 2018-2032
6.6.3 Argentina Cancer Gene Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Gene Therapy Revenue, 2018-2032
6.7.2 Turkey Cancer Gene Therapy Market Size, 2018-2032
6.7.3 Israel Cancer Gene Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia Cancer Gene Therapy Market Size, 2018-2032
6.7.5 UAE Cancer Gene Therapy Market Size, 2018-2032
7 Cancer Gene Therapy Companies Profiles
7.1 Adaptimmune
7.1.1 Adaptimmune Company Summary
7.1.2 Adaptimmune Business Overview
7.1.3 Adaptimmune Cancer Gene Therapy Major Product Offerings
7.1.4 Adaptimmune Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.1.5 Adaptimmune Key News & Latest Developments
7.2 Bluebird bio
7.2.1 Bluebird bio Company Summary
7.2.2 Bluebird bio Business Overview
7.2.3 Bluebird bio Cancer Gene Therapy Major Product Offerings
7.2.4 Bluebird bio Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.2.5 Bluebird bio Key News & Latest Developments
7.3 Celgene
7.3.1 Celgene Company Summary
7.3.2 Celgene Business Overview
7.3.3 Celgene Cancer Gene Therapy Major Product Offerings
7.3.4 Celgene Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.3.5 Celgene Key News & Latest Developments
7.4 Shanghai Sunway Biotech
7.4.1 Shanghai Sunway Biotech Company Summary
7.4.2 Shanghai Sunway Biotech Business Overview
7.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Major Product Offerings
7.4.4 Shanghai Sunway Biotech Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.4.5 Shanghai Sunway Biotech Key News & Latest Developments
7.5 Shenzhen SiBiono GeneTech
7.5.1 Shenzhen SiBiono GeneTech Company Summary
7.5.2 Shenzhen SiBiono GeneTech Business Overview
7.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Major Product Offerings
7.5.4 Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.5.5 Shenzhen SiBiono GeneTech Key News & Latest Developments
7.6 SynerGene Therapeutics
7.6.1 SynerGene Therapeutics Company Summary
7.6.2 SynerGene Therapeutics Business Overview
7.6.3 SynerGene Therapeutics Cancer Gene Therapy Major Product Offerings
7.6.4 SynerGene Therapeutics Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.6.5 SynerGene Therapeutics Key News & Latest Developments
7.7 Altor BioScience
7.7.1 Altor BioScience Company Summary
7.7.2 Altor BioScience Business Overview
7.7.3 Altor BioScience Cancer Gene Therapy Major Product Offerings
7.7.4 Altor BioScience Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.7.5 Altor BioScience Key News & Latest Developments
7.8 Amgen
7.8.1 Amgen Company Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Cancer Gene Therapy Major Product Offerings
7.8.4 Amgen Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.8.5 Amgen Key News & Latest Developments
7.9 Argenx
7.9.1 Argenx Company Summary
7.9.2 Argenx Business Overview
7.9.3 Argenx Cancer Gene Therapy Major Product Offerings
7.9.4 Argenx Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.9.5 Argenx Key News & Latest Developments
7.10 BioCancell
7.10.1 BioCancell Company Summary
7.10.2 BioCancell Business Overview
7.10.3 BioCancell Cancer Gene Therapy Major Product Offerings
7.10.4 BioCancell Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.10.5 BioCancell Key News & Latest Developments
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Company Summary
7.11.2 GlaxoSmithKline Business Overview
7.11.3 GlaxoSmithKline Cancer Gene Therapy Major Product Offerings
7.11.4 GlaxoSmithKline Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.11.5 GlaxoSmithKline Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Business Overview
7.12.3 Merck Cancer Gene Therapy Major Product Offerings
7.12.4 Merck Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.12.5 Merck Key News & Latest Developments
7.13 OncoGenex Pharmaceuticals
7.13.1 OncoGenex Pharmaceuticals Company Summary
7.13.2 OncoGenex Pharmaceuticals Business Overview
7.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Major Product Offerings
7.13.4 OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.13.5 OncoGenex Pharmaceuticals Key News & Latest Developments
7.14 Transgene
7.14.1 Transgene Company Summary
7.14.2 Transgene Business Overview
7.14.3 Transgene Cancer Gene Therapy Major Product Offerings
7.14.4 Transgene Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.14.5 Transgene Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
